Tudor Investment Corp’s Verona Pharma VRNA Stock Holding History

Tudor Investment Corp’s Portfolio VRNA Stock Details VRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-400,000	Closed	-$42.7M	–	4099
2025 Q3	$42.7M	Buy	+400,000	New	+$41.8M	0.07%	208
2025 Q2	–	Sell	-88,324	Closed	-$6.54M	–	3804
2025 Q1	$5.61M	Buy	+88,324	New	+$5.28M	0.02%	734

Other funds holding VRNA

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Tudor Investment Corp's VRNA Position: Q4 2025 in Review

Tudor Investment Corp sold out of Verona Pharma (VRNA) in Q4 2025, closing a stake of 400,000 shares — an estimated $42.7M sold.

Tudor Investment Corp first reported a position in VRNA in Q1 2025 and held it in 2 quarters. The position peaked at $42.7M in Q3 2025. 1 fund tracked by Wall St. Rank holds VRNA as of Q4 2025.

Tudor Investment Corp reported no remaining Verona Pharma position as of Q4 2025 after selling out during the quarter.
Tudor Investment Corp sold 400,000 Verona Pharma shares in Q4 2025, an estimated $42.7M.
Tudor Investment Corp first reported a position in Verona Pharma in Q1 2025 and held it in 2 quarters.
Tudor Investment Corp's Verona Pharma position peaked at $42.7M in Q3 2025.
1 fund tracked by Wall St. Rank held Verona Pharma as of Q4 2025.

Based on Tudor Investment Corp's 13F filing for Q4 2025, filed 17 Feb 2026.